M Barbara Carnemolla

Title: M Barbara Carnemolla: Innovator in Monoclonal Antibody Research

Introduction

M Barbara Carnemolla is a distinguished inventor based in Genoa, Italy. She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. Her innovative work focuses on the identification of oncofetal isoforms of fibronectin, which has important implications for diagnosis and therapy.

Latest Patents

M Barbara Carnemolla holds a patent for a monoclonal antibody and its use for the identification of the oncofetal isoform of fibronectin (B-FN). This patent describes epitopes localized on FNIII-repeat that are normally cryptic but are unmasked by the insertion of FNIII-B into the FN molecule. The patent also details antibodies or their fragments that can identify the aforementioned epitope, which are recognized by specific ligands.

Career Highlights

Throughout her career, M Barbara Carnemolla has been associated with Sirius-Biotech S.r.l., where she has furthered her research and development efforts. Her work has been pivotal in advancing the understanding of fibronectin and its role in cancer diagnostics and therapeutics.

Collaborations

M Barbara Carnemolla has collaborated with notable colleagues, including Francesca Sassi and Enrica Balza. These partnerships have enhanced her research capabilities and contributed to the success of her projects.

Conclusion

M Barbara Carnemolla's innovative work in monoclonal antibody research exemplifies her commitment to advancing medical science. Her contributions have the potential to significantly impact cancer diagnosis and therapy.